Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted Cash from Financing Activities of $609622.0 for Q1 2026, up 312.4% on a QoQ basis from $147823.0 in Q4 2025, and up 148.61% year-over-year from $245216.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $609622.0 for Q1 2026.
- Quarterly Cash from Financing Activities rose 148.61% year-over-year to $609622.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 135.68% YoY) and the FY2025 annual result came in at $8.0 million, up 10.45% from the prior year.
- Cash from Financing Activities was $609622.0 for Q1 2026 at Neuroone Medical Technologies, up from $147823.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $8.2 million in Q2 2025 and bottomed at -$509325.0 in Q4 2024.
- A 5-year average of $1.6 million and a median of $661961.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 205677.95% — and 2024, when it slumped 142.27%.
- Neuroone Medical Technologies' Cash from Financing Activities stood at -$15713.0 in 2022, then soared by 7768.9% to $1.2 million in 2023, then sank by 142.27% to -$509325.0 in 2024, then jumped by 129.02% to $147823.0 in 2025, then jumped by 312.4% to $609622.0 in 2026.
- Business Quant data shows NMTC's Cash from Financing Activities at $609622.0 in Q1 2026, $147823.0 in Q4 2025, and $66978.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 609,622.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 609,622.00 |
| Mar 31, 2026 | 609,622.00 |
| Dec 31, 2025 | 147,823.00 |
| Dec 31, 2025 | 147,823.00 |
| Sep 30, 2025 | 66,978.00 |
| Sep 30, 2025 | 66,978.00 |
| Jun 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 8.23 Mn |
| Mar 31, 2025 | 245,216.00 |
| Mar 31, 2025 | 245,216.00 |
| Dec 31, 2024 | -509,325.00 |
| Dec 31, 2024 | -509,325.00 |
| Sep 30, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |